vs

Side-by-side financial comparison of KAMADA LTD (KMDA) and NewtekOne, Inc. (NEWT). Click either name above to swap in a different company.

NewtekOne, Inc. is the larger business by last-quarter revenue ($73.3M vs $47.0M, roughly 1.6× KAMADA LTD). NewtekOne, Inc. runs the higher net margin — 111.8% vs 11.3%, a 100.5% gap on every dollar of revenue. On growth, KAMADA LTD posted the faster year-over-year revenue change (12.6% vs -2.7%). Over the past eight quarters, NewtekOne, Inc.'s revenue compounded faster (12.2% CAGR vs 12.0%).

Kamada Ltd. is a global biopharmaceutical company specializing in the research, manufacturing, and commercialization of specialty pharmaceuticals derived from human plasma.

NewTek, Inc., is a hardware and software company, based in San Antonio, Texas, that produced live and post-production video tools and visual imaging software for personal computers. The company was founded in 1985 in Topeka, Kansas, United States, by Tim Jenison and Paul Montgomery. On April 1, 2019, it was announced that NewTek would be acquired by Vizrt.

KMDA vs NEWT — Head-to-Head

Bigger by revenue
NEWT
NEWT
1.6× larger
NEWT
$73.3M
$47.0M
KMDA
Growing faster (revenue YoY)
KMDA
KMDA
+15.3% gap
KMDA
12.6%
-2.7%
NEWT
Higher net margin
NEWT
NEWT
100.5% more per $
NEWT
111.8%
11.3%
KMDA
Faster 2-yr revenue CAGR
NEWT
NEWT
Annualised
NEWT
12.2%
12.0%
KMDA

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
KMDA
KMDA
NEWT
NEWT
Revenue
$47.0M
$73.3M
Net Profit
$5.3M
$19.5M
Gross Margin
42.0%
Operating Margin
16.6%
Net Margin
11.3%
111.8%
Revenue YoY
12.6%
-2.7%
Net Profit YoY
37.1%
6.6%
EPS (diluted)
$0.09
$0.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KMDA
KMDA
NEWT
NEWT
Q4 25
$73.3M
Q3 25
$47.0M
$74.9M
Q2 25
$44.8M
$70.2M
Q1 25
$44.0M
$66.3M
Q4 24
$75.4M
Q3 24
$41.7M
$62.8M
Q2 24
$42.5M
$61.1M
Q1 24
$37.7M
$58.3M
Net Profit
KMDA
KMDA
NEWT
NEWT
Q4 25
$19.5M
Q3 25
$5.3M
$17.9M
Q2 25
$7.4M
$13.7M
Q1 25
$4.0M
$9.4M
Q4 24
$18.3M
Q3 24
$3.9M
$11.9M
Q2 24
$4.4M
$10.9M
Q1 24
$2.4M
$9.7M
Gross Margin
KMDA
KMDA
NEWT
NEWT
Q4 25
Q3 25
42.0%
Q2 25
42.3%
Q1 25
47.1%
Q4 24
Q3 24
41.3%
Q2 24
44.6%
Q1 24
44.4%
Operating Margin
KMDA
KMDA
NEWT
NEWT
Q4 25
Q3 25
16.6%
Q2 25
15.8%
Q1 25
17.7%
Q4 24
Q3 24
12.7%
Q2 24
13.3%
Q1 24
10.7%
Net Margin
KMDA
KMDA
NEWT
NEWT
Q4 25
111.8%
Q3 25
11.3%
23.9%
Q2 25
16.5%
19.5%
Q1 25
9.0%
14.1%
Q4 24
24.3%
Q3 24
9.3%
19.0%
Q2 24
10.4%
17.9%
Q1 24
6.3%
16.6%
EPS (diluted)
KMDA
KMDA
NEWT
NEWT
Q4 25
$0.64
Q3 25
$0.09
$0.67
Q2 25
$0.13
$0.52
Q1 25
$0.07
$0.35
Q4 24
$0.70
Q3 24
$0.07
$0.45
Q2 24
$0.08
$0.43
Q1 24
$0.04
$0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KMDA
KMDA
NEWT
NEWT
Cash + ST InvestmentsLiquidity on hand
$72.0M
Total DebtLower is stronger
$819.9M
Stockholders' EquityBook value
$265.2M
$397.6M
Total Assets
$377.2M
$2.7B
Debt / EquityLower = less leverage
2.06×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KMDA
KMDA
NEWT
NEWT
Q4 25
Q3 25
$72.0M
Q2 25
$66.0M
Q1 25
$76.3M
Q4 24
Q3 24
$72.0M
Q2 24
$56.5M
Q1 24
$48.2M
Total Debt
KMDA
KMDA
NEWT
NEWT
Q4 25
$819.9M
Q3 25
$748.5M
Q2 25
$657.3M
Q1 25
$774.0M
Q4 24
$708.0M
Q3 24
$655.8M
Q2 24
$652.0M
Q1 24
$662.5M
Stockholders' Equity
KMDA
KMDA
NEWT
NEWT
Q4 25
$397.6M
Q3 25
$265.2M
$386.7M
Q2 25
$260.0M
$312.2M
Q1 25
$252.0M
$302.3M
Q4 24
$296.3M
Q3 24
$255.3M
$281.8M
Q2 24
$251.2M
$274.0M
Q1 24
$251.2M
$254.1M
Total Assets
KMDA
KMDA
NEWT
NEWT
Q4 25
$2.7B
Q3 25
$377.2M
$2.4B
Q2 25
$368.2M
$2.1B
Q1 25
$375.1M
$2.1B
Q4 24
$2.1B
Q3 24
$351.2M
$1.7B
Q2 24
$351.0M
$1.6B
Q1 24
$343.2M
$1.5B
Debt / Equity
KMDA
KMDA
NEWT
NEWT
Q4 25
2.06×
Q3 25
1.94×
Q2 25
2.11×
Q1 25
2.56×
Q4 24
2.39×
Q3 24
2.33×
Q2 24
2.38×
Q1 24
2.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KMDA
KMDA
NEWT
NEWT
Operating Cash FlowLast quarter
$10.4M
$-579.2M
Free Cash FlowOCF − Capex
$-579.3M
FCF MarginFCF / Revenue
-790.0%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
1.97×
-29.64×
TTM Free Cash FlowTrailing 4 quarters
$-1.0B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KMDA
KMDA
NEWT
NEWT
Q4 25
$-579.2M
Q3 25
$10.4M
$-167.3M
Q2 25
$8.0M
$-199.8M
Q1 25
$-513.0K
$-60.7M
Q4 24
$-153.0M
Q3 24
$22.2M
$-25.7M
Q2 24
$14.0M
$2.9M
Q1 24
$1.0M
$-38.7M
Free Cash Flow
KMDA
KMDA
NEWT
NEWT
Q4 25
$-579.3M
Q3 25
$-167.3M
Q2 25
$-199.9M
Q1 25
$-60.7M
Q4 24
$-153.5M
Q3 24
$-25.9M
Q2 24
$2.9M
Q1 24
$-38.7M
FCF Margin
KMDA
KMDA
NEWT
NEWT
Q4 25
-790.0%
Q3 25
-223.3%
Q2 25
-284.7%
Q1 25
-91.6%
Q4 24
-203.6%
Q3 24
-41.2%
Q2 24
4.7%
Q1 24
-66.5%
Capex Intensity
KMDA
KMDA
NEWT
NEWT
Q4 25
0.1%
Q3 25
0.0%
Q2 25
0.1%
Q1 25
0.1%
Q4 24
0.6%
Q3 24
0.4%
Q2 24
0.1%
Q1 24
0.1%
Cash Conversion
KMDA
KMDA
NEWT
NEWT
Q4 25
-29.64×
Q3 25
1.97×
-9.35×
Q2 25
1.09×
-14.58×
Q1 25
-0.13×
-6.48×
Q4 24
-8.35×
Q3 24
5.75×
-2.15×
Q2 24
3.15×
0.27×
Q1 24
0.43×
-4.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons